Fluor® Violet 450 Anti-Mouse CD161/NK1.1 Antibody[PK136]
Cat No.: FCE1337
Size:
Product Name: | Fluor® Violet 450 Anti-Mouse CD161/NK1.1 Antibody[PK136] |
Cat No.: | FCE1337 |
host: | Mouse |
uniprot id: | P27814;P27812;Q99JB4; |
geneid: | 17059 |
application: | FCM |
isotype: | Mouse IgG2a, κ |
form: | Liquid |
storage: | This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. |
shipping: | Ice bag |
category id: | Flow Cytometry Antibodies |
abbreviation: | CD161/NK1.1 |
conjugation: | Fluor® Violet 450 |
species reactivity: | Mouse |
usage: | Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. |
clone no.: | PK136 |
background: | NK-1.1 surface antigen, also known as CD161b/CD161c and Ly-55, is encoded by the NKR-P1B/NKR-P1C gene. It is expressed on NK cells and NK-T cells in some mouse strains, including C57BL/6, FVB/N, and NZB, but not AKR, BALB/c, CBA/J, C3H, DBA/1, DBA/2, NOD, SJL, and 129. Expression of NKR-P1C antigen has been correlated with lysis of tumor cells in vitro and rejection of bone marrow allografts in vivo. NK-1.1 has also been shown to play a role in NK cell activation, IFN-γ production, and cytotoxic granule release. NK-1.1 and DX5 are commonly used as mouse NK cell markers. |
target synonym: | Killer cell lectin-like receptor subfamily B member 1C;Klrb1c;CD161 antigen-like family member C;Ly-55c;CD161/NK1.1;NKR-P1.9;NKR-P1C;NKR-P1 40;CD161c; |
concentration: | 5 μL/Test |
buffer: | Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant. |
image 1 description: | C57BL/6 murine splenocytes are stained with Fluor® Violet 450 Anti-Mouse CD161/NK1.1 Antibody and APC Anti-Mouse CD49b Antibody. |